Scientific Publications Search Search Author Impact Factor Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Beule, Dieter Dr. (1) Bunse, Mario Dr. (1) Daniel, Peter Prof. Dr. (1) Endemann, Beate Dr. (1) Fischer, Cornelius Dr. (1) Gerlach, Kerstin (2) Höpken, Uta Elisabeth PD Dr. (12) Krüger, Kerstin (1) Luft, Friedrich Prof. Dr. (1) Millward, Jason Dr. (2) Niendorf, Thoralf Prof. Dr. (23) Pischon, Tobias Prof. Dr. (3) Rahimi, Faezeh (2) Saha, Nandita (1) Simon, Mareike Dr. (1) Starke, Ludger Benedikt (1) Uckert, Wolfgang Prof. Dr. (1) Waiczies, Helmar Dr. (2) Waiczies, Sonia PD Dr. (2) Willimsky, Gerald Dr. (1) Wirges, Anthea Dr. (2) Wolf, Jana Prof. Dr. (5) (-) Rehm, Armin Dr. (14) 2001 (1) (-) 2002 (2) 2003 (1) (-) 2004 (1) (-) 2005 (3) 2007 (3) 2008 (1) (-) 2009 (3) 2012 (4) 2013 (9) 2014 (4) 2015 (10) 2016 (9) 2017 (10) 2018 (7) 2019 (7) 2020 (13) 2021 (26) (-) 2022 (8) 2023 (1) 2024 (2) AG Müller/Dechend (ECRC) (1) Anchored Signalling (1) Animal Phenotyping (1) Clinical Research Unit (1) (-) Experimental Ultrahigh-Field MR (3) Genetics and Genomics of Cardiovascular Diseases (1) Genomics (1) Host-microbiome factors in cardiovascular disease (1) Hypertension-caused End-Organ Damage (1) Hypertension-Mediated End-Organ Damage (1) Magnetic Resonance (3) (-) Mathematical Modelling of Cellular Processes (1) Microenvironmental Regulation in Autoimmunity and Cancer (13) Mobile DNA (1) Molecular Biology of Peptide Hormones (1) Molecular Cardiovascular Research (1) Molecular Pathways in Cortical Development (1) Pluripotent Stem Cells (1) Proteome Dynamics (1) Translational Bioinformatics (1) (-) Translational Tumorimmunology (13) 17 Results: Active Filter: Rehm, Armin Dr.Experimental Ultrahigh-Field MRMathematical Modelling of Cellular ProcessesTranslational Tumorimmunology20022004200520092022 Sort: Result score Newest to oldest Oldest to newest January 01, 2005 / BMC Cancer Reevaluation of the 22-1-1 antibody and its putative antigen, EBAG9/RCAS1, as a tumor marker T.A. Reimer I. Anagnostopoulos B. Erdmann I. Lehmann H. Stein P. Daniel B. Doerken A. Rehm September 10, 2004 / Biochem Biophys Res Commun HCMV-encoded chemokine receptor US28 employs multiple routes for internalization J. Droese T. Mokros R. Hermosilla R. Schuelein M. Lipp U.E. Höpken A. Rehm January 05, 2005 / Mol Biol Cell EBAG9 adds a new layer of control on large dense-core vesicle exocytosis via interaction with Snapin C. Rueder T. Reimer I. Delgado-Martinez R. Hermosilla A. Engelsberg R. Nehring B. Doerken A. Rehm May 13, 2009 / Brain Res Longitudinal regional brain volume changes quantified in normal aging and Alzheimer's APP x PS1 mice using MRI S. Maheswaran H. Barjat D. Rueckert S.T. Bate D.R. Howlett L. Tilling S.C. Smart A. Pohlmann J.C. Richardson T. Hartkens D.L.G. Hill N. Upton J.V. Hajnal M.F. James April 01, 2009 / Inflamm Bowel Dis Progression and variability of TNBS colitis-associated inflammation in rats assessed by contrast-enhanced and T2-weighted MRI A. Pohlmann L.C. Tilling A. Robinson O. Woolmer S. McCleary L. Kruidenier L.C. Warnock H.D. Lewis A.R. Hobson M.F. James September 23, 2005 / Eur J Immunol The ratio between dendritic cells and T cells determines the outcome of their encounter: Proliferation versus deletion U.E. Höpken I. Lehmann J. Droese M. Lipp T. Schueler A. Rehm August 01, 2009 / J Clin Invest The tumor-associated antigen EBAG9 negatively regulates the cytolytic capacity of mouse CD8+ T cells C. Rueder U.E. Höpken J. Wolf H.W. Mittruecker B. Engels B. Erdmann S. Wollenzin W. Uckert B. Dörken A. Rehm November 29, 2022 / Nat Commun Quadruple gene-engineered natural killer cells enable multi-antigen targeting for durable antitumor activity against multiple myeloma F. Cichocki R. Bjordahl J.P. Goodridge S. Mahmood S. Gaidarova R. Abujarour Z.B. Davis A. Merino K. Tuininga H. Wang A. Kumar B. Groff A. Witty G. Bonello J. Huffman T. Dailey T.T. Lee K.J. Malmberg B. Walcheck U. Höpken A. Rehm B. Valamehr J.S. Miller April 01, 2022 / Magn Reson Med B(1) inhomogeneity correction of RARE MRI at low SNR: quantitative in vivo (19)F MRI of mouse neuroinflammation with a cryogenically-cooled transceive surface radiofrequency probe P.R. Delgado A. Kuehne M. Aravina J.M. Millward A. Vazquez L. Starke H. Waiczies A. Pohlmann T. Niendorf S. Waiczies March 10, 2022 / Mol Ther Methods Clin Dev Accelerating clinical scale production of BCMA CAR T cells with defined maturation stages J.J. Joedicke U. Großkinsky K. Gerlach A. Künkele U.E. Höpken A. Rehm Pagination Current page 1 Page 2 Next page Next › Last page Last »
January 01, 2005 / BMC Cancer Reevaluation of the 22-1-1 antibody and its putative antigen, EBAG9/RCAS1, as a tumor marker T.A. Reimer I. Anagnostopoulos B. Erdmann I. Lehmann H. Stein P. Daniel B. Doerken A. Rehm
September 10, 2004 / Biochem Biophys Res Commun HCMV-encoded chemokine receptor US28 employs multiple routes for internalization J. Droese T. Mokros R. Hermosilla R. Schuelein M. Lipp U.E. Höpken A. Rehm
January 05, 2005 / Mol Biol Cell EBAG9 adds a new layer of control on large dense-core vesicle exocytosis via interaction with Snapin C. Rueder T. Reimer I. Delgado-Martinez R. Hermosilla A. Engelsberg R. Nehring B. Doerken A. Rehm
May 13, 2009 / Brain Res Longitudinal regional brain volume changes quantified in normal aging and Alzheimer's APP x PS1 mice using MRI S. Maheswaran H. Barjat D. Rueckert S.T. Bate D.R. Howlett L. Tilling S.C. Smart A. Pohlmann J.C. Richardson T. Hartkens D.L.G. Hill N. Upton J.V. Hajnal M.F. James
April 01, 2009 / Inflamm Bowel Dis Progression and variability of TNBS colitis-associated inflammation in rats assessed by contrast-enhanced and T2-weighted MRI A. Pohlmann L.C. Tilling A. Robinson O. Woolmer S. McCleary L. Kruidenier L.C. Warnock H.D. Lewis A.R. Hobson M.F. James
September 23, 2005 / Eur J Immunol The ratio between dendritic cells and T cells determines the outcome of their encounter: Proliferation versus deletion U.E. Höpken I. Lehmann J. Droese M. Lipp T. Schueler A. Rehm
August 01, 2009 / J Clin Invest The tumor-associated antigen EBAG9 negatively regulates the cytolytic capacity of mouse CD8+ T cells C. Rueder U.E. Höpken J. Wolf H.W. Mittruecker B. Engels B. Erdmann S. Wollenzin W. Uckert B. Dörken A. Rehm
November 29, 2022 / Nat Commun Quadruple gene-engineered natural killer cells enable multi-antigen targeting for durable antitumor activity against multiple myeloma F. Cichocki R. Bjordahl J.P. Goodridge S. Mahmood S. Gaidarova R. Abujarour Z.B. Davis A. Merino K. Tuininga H. Wang A. Kumar B. Groff A. Witty G. Bonello J. Huffman T. Dailey T.T. Lee K.J. Malmberg B. Walcheck U. Höpken A. Rehm B. Valamehr J.S. Miller
April 01, 2022 / Magn Reson Med B(1) inhomogeneity correction of RARE MRI at low SNR: quantitative in vivo (19)F MRI of mouse neuroinflammation with a cryogenically-cooled transceive surface radiofrequency probe P.R. Delgado A. Kuehne M. Aravina J.M. Millward A. Vazquez L. Starke H. Waiczies A. Pohlmann T. Niendorf S. Waiczies
March 10, 2022 / Mol Ther Methods Clin Dev Accelerating clinical scale production of BCMA CAR T cells with defined maturation stages J.J. Joedicke U. Großkinsky K. Gerlach A. Künkele U.E. Höpken A. Rehm